Sign In
Buy HUGE
$0.0899
+0 (+0%)
At Close: Nov 15, 2024
Cannabis Stocks Felt the Reddit Rumble This Week
02:29pm, Friday, 12'th Feb 2021
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will c
FSD Pharma signs agreement covering the sale of Class B shares on an 'at-the-market' basis
11:46am, Thursday, 11'th Feb 2021
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) said it has entered into an equity sales agreement with A.G.P./Alliance Global Partners covering the sale of Class B subordinate voting shares of the compan
FSD Pharma Announces US$20M At-The-Market Offering
08:40am, Thursday, 11'th Feb 2021
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that it has entered into an Equity Distribution Agreement dated February 11, 2021 (th
8 Pot Stocks in Focus Amid the WallStreetBets Frenzy
11:38am, Monday, 01'st Feb 2021
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will d
FSD Provides Corporate Update
07:30pm, Tuesday, 26'th Jan 2021
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces the following corporate updates. Corporate Update The Company continues to
FSD Pharma Sets Date for Annual Meeting
04:30pm, Friday, 22'nd Jan 2021
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (“FSD Pharma” or the “Company”) today announced that it will hold its annual meeting of shareholders (the “Meeting”) on J
FSD Pharma Announces First Patient Randomized in Phase 2 Trial of FSD201 for the Treatment of Hospitalized Patients with COVID-19
08:35am, Tuesday, 15'th Dec 2020
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced the dosing of the first patient in its Phase 2a clinical trial of FSD201 (u
11 Cannabis Stocks Making Moves While Riding the 'Green Wave'
02:29pm, Friday, 13'th Nov 2020
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and we will look ahead at the pot stocks to watch in
AstraZeneca's Farxiga Data, And Other News: The Good, Bad And Ugly Of Biopharma
05:36am, Wednesday, 02'nd Sep 2020
AstraZeneca reports positive data for Phase III Farxiga trial. Aimmune Therapeutics to be acquired by Nestle.
FSD Pharma Reports Second Quarter 2020 Financial Results
09:45pm, Friday, 07'th Aug 2020
\\- Provides Business Update -TORONTO / ACCESSWIRE / August 7, 2020 / FSD Pharma Inc.
FSD Pharma Inc. Announces Closing of US$10 Million Registered Direct Offering to Institutional Investors
09:00pm, Thursday, 06'th Aug 2020
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) ("FSD Pharma" or the "Company") announces the closing of a previously announced agreement with investors for the purchase and sale of 2,762,430 Class B Su
FSD Pharma Inc., Developing its PEA Compound to Treat COVID-19, CEO Clip Video
08:49pm, Friday, 31'st Jul 2020
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) CEO and Chairman, Raza Bokhari speaks about the company's lead Compound, PEA, to treat COVID-
FSD Pharma Inc. Announces US$10 Million Registered Direct Offering
01:00pm, Friday, 31'st Jul 2020
TORONTO, ON / ACCESSWIRE / July 31, 2020 / FSD Pharma Inc.
FSD Pharma Announces Decision to Surrender Health Canada Licenses for Subsidiary FV Pharma Inc.
06:30am, Thursday, 30'th Jul 2020
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced that it has notified Health Canada of the Company’s decision to forfeit the licenses of its
FSD Pharma Announces US$20M At-The-Market Offering
06:30am, Monday, 13'th Jul 2020
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) ("FSD Pharma" or the "Company") today announced that it has entered into an Equity Distribution Agreement dated July 10, 2020 (the "Sales Agreement") with
